MAJOR DEPRESSIVE DISORDER; MDD

Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary

Literature (2)

Literature for OMIM 608516: MAJOR DEPRESSIVE DISORDER; MDD

Xenbase Articles:
(

Denotes literature images)

Doxepin and imipramine but not fluoxetine reduce the activity of the rat glutamate transporter EAAT3 expressed in Xenopus oocytes., Park HJ,Baik HJ,Kim DY,Lee GY,Woo JH,Zuo Z,Chung RK, BMC Anesthesiol. August 8, 2015; 15:1471-2253.
Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptors., Bretin S,Louis C,Seguin L,Wagner S,Thomas JY,Challal S,Rogez N,Albinet K,Iop F,Villain N,Bertrand S,Krazem A,Bérachochéa D,Billiald S,Tordjman C,Cordi A,Bertrand D,Lestage P,Danober L, PLoS One. September 8, 2017; 12(9):1932-6203.

Doxepin and imipramine but not fluoxetine reduce the activity of the rat glutamate transporter EAAT3 expressed in Xenopus oocytes., Park HJ,Baik HJ,Kim DY,Lee GY,Woo JH,Zuo Z,Chung RK, BMC Anesthesiol. August 8, 2015; 15:1471-2253.

Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptors., Bretin S,Louis C,Seguin L,Wagner S,Thomas JY,Challal S,Rogez N,Albinet K,Iop F,Villain N,Bertrand S,Krazem A,Bérachochéa D,Billiald S,Tordjman C,Cordi A,Bertrand D,Lestage P,Danober L, PLoS One. September 8, 2017; 12(9):1932-6203.